Neal M Nolan1, Robert W Regenhardt2, Matthew J Koch3, Scott B Raymond4, Christopher J Stapleton3, James D Rabinov4, Scott B Silverman1, Thabele M Leslie-Mazwi5, Aman B Patel3. 1. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA. 2. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA. Electronic address: Robert.Regenhardt@mgh.harvard.edu. 3. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA. 4. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA. 5. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.
Abstract
OBJECTIVES: Endovascular thrombectomy (EVT) has revolutionized stroke care for large vessel occlusions (LVOs). However, over half treated remain functionally disabled or die. Patients with tandem lesions, or severe stenosis/occlusion of the cervical internal carotid artery (ICA) with intracranial LVO, may have technical EVT challenges and worse outcomes. We sought to compare treatments and outcomes for patients with anterior circulation tandem lesions versus isolated LVOs. MATERIALS AND METHODS: Consecutive tandem lesion and isolated intracranial LVO patients were identified at a single center. Demographics, medical history, presentations, treatments, and outcomes were collected and analyzed. RESULTS: From 381 EVT patients, 62 had tandem lesions related to atherosclerosis (74%) or dissection (26%). Compared to isolated intracranial LVOs, they were younger (63 vs 70, p = 0.003), had less atrial fibrillation (13% vs 40%, p < 0.0001), less adequate reperfusion (TICI 2b-3, 58% vs 82%, p < 0.0001), more intracranial hemorrhage (ICH, 13% vs 5%, p = 0.037), but similar 90-day functional independence (mRS 0-2, 34% vs 43%, p = 0.181). The cervical ICA was treated before intracranial EVT (57%), after (13%), not acutely (22%), or was inaccessible (8%). Acute cervical ICA treatments were stenting (57%) or angioplasty alone (13%). Neither acute stenting nor order of treatment was associated with outcomes (TICI 2b-3, ICH, or 90-day mRS 0-2). Among acutely stented, neither alteplase nor antiplatelets were associated with outcomes or stent patency. CONCLUSIONS: Tandem lesions were associated with less reperfusion, more ICH, but similar 90-day functional independence. No treatment approach was associated with outcomes. These data illustrate the technical challenges of tandem lesion treatment and underscore the importance of developing new approaches.
OBJECTIVES: Endovascular thrombectomy (EVT) has revolutionized stroke care for large vessel occlusions (LVOs). However, over half treated remain functionally disabled or die. Patients with tandem lesions, or severe stenosis/occlusion of the cervical internal carotid artery (ICA) with intracranial LVO, may have technical EVT challenges and worse outcomes. We sought to compare treatments and outcomes for patients with anterior circulation tandem lesions versus isolated LVOs. MATERIALS AND METHODS: Consecutive tandem lesion and isolated intracranial LVO patients were identified at a single center. Demographics, medical history, presentations, treatments, and outcomes were collected and analyzed. RESULTS: From 381 EVT patients, 62 had tandem lesions related to atherosclerosis (74%) or dissection (26%). Compared to isolated intracranial LVOs, they were younger (63 vs 70, p = 0.003), had less atrial fibrillation (13% vs 40%, p < 0.0001), less adequate reperfusion (TICI 2b-3, 58% vs 82%, p < 0.0001), more intracranial hemorrhage (ICH, 13% vs 5%, p = 0.037), but similar 90-day functional independence (mRS 0-2, 34% vs 43%, p = 0.181). The cervical ICA was treated before intracranial EVT (57%), after (13%), not acutely (22%), or was inaccessible (8%). Acute cervical ICA treatments were stenting (57%) or angioplasty alone (13%). Neither acute stenting nor order of treatment was associated with outcomes (TICI 2b-3, ICH, or 90-day mRS 0-2). Among acutely stented, neither alteplase nor antiplatelets were associated with outcomes or stent patency. CONCLUSIONS: Tandem lesions were associated with less reperfusion, more ICH, but similar 90-day functional independence. No treatment approach was associated with outcomes. These data illustrate the technical challenges of tandem lesion treatment and underscore the importance of developing new approaches.
Authors: Volker Maus; Jan Borggrefe; Daniel Behme; Christoph Kabbasch; Nuran Abdullayev; Utako Birgit Barnikol; Leonard Leong Litt Yeo; Patrick A Brouwer; Michael Söderman; Markus Möhlenbruch; Thomas Liebig; Gereon Rudolf Fink; Anastasios Mpotsaris Journal: Cerebrovasc Dis Date: 2018-08-09 Impact factor: 2.762
Authors: Mohammad Anadani; Alejandro Spiotta; Ali Alawieh; Francis Turjman; Michel Piotin; Henrik Steglich-Arnholm; Markus Holtmannspötter; Christian Taschner; Sebastian Eiden; Diogo C Haussen; Raul Nogueira; Panagiotis Papanagiotou; Maria Boutchakova; Adnan H Siddiqui; Bertrand Lapergue; Franziska Dorn; Christophe Cognard; Monika Killer-Oberpfalzer; Salvatore Mangiafico; Marc Ribo; Marios-Nikos Psychogios; Marc-Antoine Labeyrie; Mikael Mazighi; Alessandra Biondi; René Anxionnat; Serge Bracard; Sébastien Richard; Benjamin Gory Journal: J Neurointerv Surg Date: 2019-03-06 Impact factor: 5.836
Authors: Leonardo Rangel-Castilla; Gary B Rajah; Hakeem J Shakir; Hussain Shallwani; Sirin Gandhi; Jason M Davies; Kenneth V Snyder; Elad I Levy; Adnan H Siddiqui Journal: Neurosurg Focus Date: 2017-04 Impact factor: 4.047
Authors: Gregoire Boulouis; Khawja-Ahmeruddin Siddiqui; Arne Lauer; Andreas Charidimou; Robert W Regenhardt; Anand Viswanathan; Thabele M Leslie-Mazwi; Natalia Rost; Lee H Schwamm Journal: Stroke Date: 2017-07-07 Impact factor: 7.914
Authors: H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw Journal: N Engl J Med Date: 1991-08-15 Impact factor: 91.245
Authors: A T Yu; R W Regenhardt; C Whitney; L H Schwamm; A B Patel; C J Stapleton; A Viswanathan; J A Hirsch; M Lev; T M Leslie-Mazwi Journal: AJNR Am J Neuroradiol Date: 2021-02-04 Impact factor: 3.825
Authors: Robert W Regenhardt; Anna K Bonkhoff; Martin Bretzner; Mark R Etherton; Alvin S Das; Sungmin Hong; Naif M Alotaibi; Justin E Vranic; Adam A Dmytriw; Christopher J Stapleton; Aman B Patel; Thabele M Leslie-Mazwi; Natalia S Rost Journal: Neurology Date: 2022-01-31 Impact factor: 9.910
Authors: Robert W Regenhardt; R Gilberto González; Julian He; Michael H Lev; Aneesh B Singhal Journal: Radiology Date: 2021-11-02 Impact factor: 11.105
Authors: Robert W Regenhardt; Ashby C Turner; Joshua A Hirsch; Michael J Young; Naif M Alotaibi; Christopher J Stapleton; Aman B Patel; Thabele M Leslie-Mazwi; Natalia S Rost; Mark R Etherton Journal: J Neurol Date: 2021-05-29 Impact factor: 4.849
Authors: Robert W Regenhardt; Mark R Etherton; Alvin S Das; Markus D Schirmer; Joshua A Hirsch; Christopher J Stapleton; Aman B Patel; Thabele M Leslie-Mazwi; Natalia S Rost Journal: J Stroke Cerebrovasc Dis Date: 2020-12-29 Impact factor: 2.136